However, no study has been conducted to systematically evaluate the molecular mechanisms of Nampt in arthritis in well-established Nampt knockdown (Nampt+/−) and Nampt overexpression (NamptOE) mice to substantiate that Nampt is a genetic risk factor and potential therapeutic target in RA. Here, NAMPT is linked to arthritic joint disease.